Middle East, North Africa, Afghanistan & Pakistan (excluding high income) vs Romania: Treatment for hypertension

Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
39.9%
in 2019
Romania
59.0%
in 2019
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank
21st
Romania rank
23rd

Treatment for hypertension over time

  • Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
  • Romania
0204060199020042019

How they compare

Romania currently reports 59.0% against 39.9% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), a difference of 19.1%.

That makes Romania's figure about 1.5 times Middle East, North Africa, Afghanistan & Pakistan (excluding high income)'s.

Across all 30 years both countries report, Romania has been ahead every year.

Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 21st and Romania ranks 23rd of 43 groups.

Romania has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Middle East, North Africa, Afghanistan & Pakistan (excluding high income) Romania Difference Ahead
1990s 23.7% 33.8% 10.1% Romania
2000s 32.2% 45.3% 13.0% Romania
2010s 39.0% 55.4% 16.4% Romania

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment for hypertension, Middle East, North Africa, Afghanistan & Pakistan (excluding high income) or Romania?
Romania, at 59.0% against 39.9% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) as of 2019.
What is the difference in treatment for hypertension between Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Romania?
19.1%, with Romania ahead.
How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Romania?
30 years are reported by both, from 1990 to 2019.
How do Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Romania rank globally for treatment for hypertension?
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 21st and Romania ranks 23rd of 43 groups.
Where does this data come from?
World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension (% of adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Middle East, North Africa, Afghanistan & Pakistan (excluding high income) vs Romania: Treatment for hypertension. Statizoid, drawing on World Health Organization's Global Health Observatory Data Repository. Retrieved 19 September 2026, from https://health.statizoid.com/compare/treatment-for-hypertension-percent-of-adults-ages-30-79-with-hypertension/middle-east-north-africa-afghanistan-and-pakistan-excluding-high-income/romania/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-for-hypertension-percent-of-adults-ages-30-79-with-hypertension/middle-east-north-africa-afghanistan-and-pakistan-excluding-high-income/romania/">Middle East, North Africa, Afghanistan & Pakistan (excluding high income) vs Romania: Treatment for hypertension</a> — Statizoid

About this data

Indicator
Treatment for hypertension (% of adults ages 30-79 with hypertension)
Unit
% of adults ages 30-79 with hypertension
Source
World Health Organization's Global Health Observatory Data Repository
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
235 places, 7,050 data points, 1990–2019
Last refreshed

Treatment for hypertension is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.